W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number TGM343420J |
Device Problem
Material Separation (1562)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/13/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.
|
|
Manufacturer Narrative
|
W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
The following information was reported to gore: on (b)(6) 2024, this patient underwent endovascular treatment for a thoracic aortic type b dissection using gore® tag® conformable thoracic stent grafts with active control system.To implant the device just below the left subclavian artery, an unwrapping technique (to remove the double wrapping under the leading olive using hemostats and scalpels, leaving the sleeve on the lesser curvature) was performed at the physician¿s decision.It is also identified as a ¿sleeve cut¿.There was resistance while advancing the device into the aortic arch.When they pulled the primary deployment line for the initial deployment, the line got broken.The deployment line access hatch was opened and the deployment line in the channel labelled 1 was pulled, but it got broken again.The device was removed as it was not yet deployed, and the procedure was continued using the alternative stent graft.The patient tolerated the procedure.Physician¿s comment: ¿there may have been a problem with an unwrapping technique, or the deployment line got broken due to the curve of the patient¿s aortic arch.
|
|
Search Alerts/Recalls
|
|
|